# East West Bancorp, Inc. (EWBC)

> Source: Nexqual · https://nexqual.com/EWBC · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, East West Bancorp, Inc. (EWBC), nexqual.com/EWBC" · informational, not investment advice.

**Price:** USD 132.65 (+0.96% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 131.39 · day 130.4–133.02 · 52w 98.08–137.47 · market cap $18.2B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $3.10B, net income $1.45B (46.6% margin) (SEC filings).
- Valuation: P/E 12.6x (avg 10.7x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold EWBC (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Insider open-market sales, last ~7 months: 10 Form 4 filings, $12.1M; 10 not under a Rule 10b5-1 plan ($12.1M); 4 by opportunistic insiders (4 outside 10b5-1 plans), 2 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (16 analysts), mean target USD 150.63 (range 137–168).
- Total return with dividends: 1Y +33.4% vs S&P 500 +14.9%; 5Y +78.3% vs S&P 500 +80.3%.
- Next earnings: 2027-01-19, EPS estimate USD 2.82, revenue estimate $837M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.82B | $2.34B | $2.61B | $2.61B | $2.93B | $3.10B |
| Net income | $873M | $1.13B | $1.16B | $1.17B | $1.33B | $1.45B |
| EPS (diluted) | $6.10 | $7.92 | $8.18 | $8.33 | $9.52 | — |
| Free cash flow | $1.16B | — | — | — | — | — |
| Net margin | 48.0% | 48.1% | 44.6% | 44.6% | 45.2% | 46.6% |
| Revenue growth | +12.7% | +29.0% | +11.1% | +0.3% | +12.2% | — |
| Cash + short-term investments | $3.91B | $3.48B | $4.61B | $5.25B | $4.19B | — |
| Total debt | $152M | $152M | $153M | $36.0M | $35.6M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 12.6x · P/S 5.9x · P/B 2.0x · Earnings yield 7.96% · Buyback yield (TTM) 0.68%
P/E at fiscal year-ends: Dec 2025 11.8x, Dec 2024 11.5x, Dec 2023 8.8x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold EWBC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Li Lu | Himalaya Capital Management | 9.68% | $358M | Unchanged |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 10 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Alvarez Manuel Pham | Director | 810 | $106K | 7.1% | No | Too little history (no open-market trades in 2024 or 2025) |
| 2026-08-12 | Liu Jack C | Director | 1,000 | $135K | 6.8% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-06 | Krause Douglas Paul | Vice Chairman | 10,000 | $1.3M | 21.3% | No | Routine (sold in Nov each year 2023–2025; this trade is outside those months) |
| 2026-06-15 | Oh Irene H | Chief Risk Officer | 800 | $107K | 0.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-12 | Oh Irene H | Chief Risk Officer | 500 | $66K | 0.6% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-11 | Oh Irene H | Chief Risk Officer | 11,211 | $1.4M | 11.2% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-27 | Krause Douglas Paul | Vice Chairman | 10,000 | $1.2M | 11.7% | No | Routine (sold in Nov each year 2023–2025; this trade is outside those months) |
| 2026-05-06 | Ng Dominic | Chief Executive Officer | 30,000 | $3.8M | 4% | No | Too little history (no open-market trades in 2024) |
| 2026-05-05 | Ng Dominic | Chief Executive Officer | 30,000 | $3.7M | 3.9% | No | Too little history (no open-market trades in 2024) |
| 2026-04-30 | Deskus Archana | Director | 1,800 | $226K | 12% | No | Too little history (no open-market trades in 2024 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 16 analysts; mean target USD 150.63 (low 137, high 168).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Citigroup | Target raised | Buy | $152 → $155 |
| 2026-10-21 | TD Cowen | Target raised | Buy | $150 → $153 |
| 2026-10-21 | Morgan Stanley | Target raised | Overweight | $164 → $168 |
| 2026-10-14 | Cantor Fitzgerald | Target lowered | Overweight | $152 → $146 |
| 2026-10-09 | Truist Securities | Target lowered | Hold | $137 → $131 |
| 2026-09-30 | Wells Fargo | Target lowered | Overweight | $155 → $150 |
| 2026-09-28 | Morgan Stanley | Target raised | Overweight | $160 → $164 |
| 2026-09-22 | Citigroup | Target lowered | Buy | $156 → $152 |
| 2026-09-18 | TD Cowen | Target raised | Buy | $148 → $150 |
| 2026-09-08 | Morgan Stanley | Upgrade | Equal-Weight → Overweight | $131 → $160 |
| 2026-08-10 | Wells Fargo | Target raised | Overweight | $140 → $155 |
| 2026-08-03 | Barclays | Target raised | Overweight | $150 → $155 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +33.4% | +78.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +33.6% | +12.2% |
| Volatility (annualized) | 22.6% | 33.5% |
| Max drawdown | -15.7% (Feb 2026→Mar 2026) | -49.3% (Jan 2022→May 2023) |

## Peers (Banks - Regional)
BBD (Banco Bradesco Sa) USD 3.95 -2.47% · FITB (Fifth Third Bancorp) USD 53.23 +0.80% · DB (Deutsche Bank AG) USD 31.48 -2.39% · TFC (Truist Financial Corporation) USD 48.42 +1.45% · NWG (NatWest Group plc) USD 16.99 -2.30% · NU (Nu Holdings Ltd.) USD 14.73 -2.13%

## More
Full page: https://nexqual.com/EWBC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-12-31) | $2.82 | $2.73 | +3.3% | $836.7M | 15 |
| Next quarter (ends 2027-03-31) | $2.73 | $2.69 | +1.4% | $838.7M | 12 |
| Current fiscal year (ends 2026-12-31) | $10.78 | $10.64 | +1.3% | $3.22B | 14 |
| Next fiscal year (ends 2027-12-31) | $11.75 | $11.35 | +3.5% | $3.49B | 15 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2027-04-16 (includes earnings 2027-01-19): ±13.6%; earnings reaction alone ±6.8%; last 8 reports averaged ±4.1%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 24.8% | ±5.9% |
| 2026-12-18 | 56 | 21.5% | ±7.0% |
| 2027-01-15 | 84 | 21.3% | ±8.4% |
| 2027-04-16 | 175 | 24.5% | ±13.6% |
| 2027-05-21 | 210 | 24.3% | ±14.7% |
| 2027-06-17 | 237 | 24.4% | ±15.6% |